Menopause happens at different times for different women, but it generally occurs between the ages of 40 and 58. This is an active time in the life of a woman. These years may include working a full-time job, sending children to college and caring for aging parents.
This busy schedule leaves little time for dealing with the dramatic changes brought on by menopause. However, understanding the causes and symptoms of menopause can help women and their loved ones deal with this natural event.
Read the story here
Friday, June 27, 2008
Estrogen may protect against colorectal cancer
Female colon cancer patients who are 50 or younger have much better odds of surviving the disease than their male peers, but the opposite is true of older women with the disease, Australian researchers report.
"The age of 50 years is a surrogate for menopause, and the protective effects of estrogen on colorectal cancer may be the explanation," Dr. Jenn H. Koo of Sydney South West Area Health Service and her colleagues suggest.
Click here for the story
"The age of 50 years is a surrogate for menopause, and the protective effects of estrogen on colorectal cancer may be the explanation," Dr. Jenn H. Koo of Sydney South West Area Health Service and her colleagues suggest.
Click here for the story
Monday, June 16, 2008
Hot flashes underreported and linked to forgetfulness
Women in midlife underreport the number of hot flashes that they experience by more than 40 percent, and these hot flashes are linked to poor verbal memory, according to a study by researchers at the University of Illinois at Chicago.
The study is published online and will appear in the September/October issue of the journal Menopause.
It is the first study to explore the relationship between objectively measured hot flashes and memory performance.
Memory complaints are common at midlife, and previous research indicates that about 40 percent of midlife women report forgetfulness.
Read story here
The study is published online and will appear in the September/October issue of the journal Menopause.
It is the first study to explore the relationship between objectively measured hot flashes and memory performance.
Memory complaints are common at midlife, and previous research indicates that about 40 percent of midlife women report forgetfulness.
Read story here
Friday, June 13, 2008
Dieting & Weight Loss Facts
-- most women that diet don't even need to lose weight
-- frequent dieting is a short-term solution that can lead to long-term health problems.
-- "dieting" is now a massive global industry, with diet plans, books, courses and products making billions in revenue
- most of the buyers of those products are women
-- advertising campaigns for these products are directed at women 9 times out of 10
-- women diet because of social pressures, they have a preconceived notion of what society expects them to be and look like
-- women are more likely to develop eating disorders than men
-- On any given day about half of all American women (and girls) are on a diet. (that is a scary number)
-- Having a BMI (body mass index) over 28 or being substantially overweight (more than 20 pounds) raises the risk of developing diabetes, polycystic ovarian syndrome (PCOS), cardiovascular disease, infertility, hypertension, arthritis, or the serious combination of insulin resistance and cardiovascular conditions.
-- According to doctors an ideal weight would be inside the healthy weight range for women as defined by the Body Mass Index - a BMI between 19 and 24.9.
-- overweight women are more prone to have pregnancy complications
-- In women, overweight and obesity are higher among members of racial and ethnic minority populations than in non-Hispanic white women.
-- Obese and overweight women are at increased risk of getting suspicious results from screening mammograms
-- frequent dieting is a short-term solution that can lead to long-term health problems.
-- "dieting" is now a massive global industry, with diet plans, books, courses and products making billions in revenue
- most of the buyers of those products are women
-- advertising campaigns for these products are directed at women 9 times out of 10
-- women diet because of social pressures, they have a preconceived notion of what society expects them to be and look like
-- women are more likely to develop eating disorders than men
-- On any given day about half of all American women (and girls) are on a diet. (that is a scary number)
-- Having a BMI (body mass index) over 28 or being substantially overweight (more than 20 pounds) raises the risk of developing diabetes, polycystic ovarian syndrome (PCOS), cardiovascular disease, infertility, hypertension, arthritis, or the serious combination of insulin resistance and cardiovascular conditions.
-- According to doctors an ideal weight would be inside the healthy weight range for women as defined by the Body Mass Index - a BMI between 19 and 24.9.
-- overweight women are more prone to have pregnancy complications
-- In women, overweight and obesity are higher among members of racial and ethnic minority populations than in non-Hispanic white women.
-- Obese and overweight women are at increased risk of getting suspicious results from screening mammograms
Thursday, June 05, 2008
Worst Menopause Symptoms May Start in Brain
Study challenges old notion that menopause starts in the ovariesSome of the most unpleasant symptoms of menopause, such as hot flashes and night sweats, have long been believed to originate in the ovaries.
But new research challenges that assumption, and instead suggests that menopausal symptoms, at least in part, may begin in the brain.
That's because the hypothalamus and the pituitary gland stop reacting normally to estrogen in some women, suggesting they may have developed a reduced sensitivity to estrogen, researchers at the New Jersey Medical School report in the Dec. 22/29 issue of the Journal of the American Medical Association.
"This is an important new concept: Menopause doesn't just originate in the ovary, but also in the brain," said Laura Goldsmith, a professor of obstetrics and gynecology and women's health at the New Jersey Medical School of the University of Medicine and Dentistry of New Jersey.
These findings may lead the way to further research that will ultimately help doctors predict the type of menopausal transition a woman might have, and help to design non-estrogen medications that could help reduce symptoms that women experience as they enter this phase of life, said Dr. Gerson Weiss, chairman of obstetrics and gynecology and women's health at the New Jersey Medical School.
Menopause refers to the time when menstruation stops. A woman is not considered menopausal until she has not had a period for 12 consecutive months, according to the North American Menopausal Society. The time before menopause, which is often rife with symptoms due to hormonal fluctuations, is called perimenopause. During perimenopause, common symptoms include hot flashes, trouble sleeping, vaginal dryness, mood swings and irregular periods.
This study stemmed from research done for the Study of Women's Health Across the Nation (SWAN), which was funded by the National Institutes of Health, that examined women's' health as they approached menopause.
The SWAN study included more than 3,300 women between the ages of 42 and 52 at the start of the study. A subset group of 840 women provided daily urine samples, which were tested for hormone levels. The samples were collected daily for one full menstrual cycle or 50 days, whichever came first.
From that group, the researchers learned that 160 did not ovulate. After further analyzing the hormone levels from the non-ovulating women, the researchers discovered that these women fell into three distinct groups.
The first group had an increase in their levels of estrogen, and then had an appropriate surge of luteinizing hormone (LH) that should have triggered ovulation, but didn't. According to Weiss, this lack of response indicated a problem originating in the ovary.
In the second group, estrogen levels peaked, but there was no correlating surge in LH, which Weiss said should be triggered by the hypothalamus and pituitary gland responding to higher estrogen levels.
The third group had similar estrogen levels early in their cycles, but didn't have an increase in estrogen later as the first and second groups did. LH levels didn't surge, but were higher for most of the cycle than they were in the other groups.
According to Weiss, this is "clear evidence that the brain is not responding to hormones," suggesting the second and third groups showed different kinds of decreased sensitivity to estrogen in the brain.
The women in the third group were also the ones most likely to report symptoms, such as hot flashes and night sweats.
Goldsmith said the researchers hope to continue studying these women. She said they'd especially like to learn how the timing of menopause correlates with their findings. For example, the researchers would like to see if the women in the third group were, perhaps, further along in the menopausal process.
"It appears that what's going on in menopause isn't only ovarian," said Dr. Steven Goldstein, a professor of obstetrics and gynecology at New York University School of Medicine. "We thought the pituitary responded to lower levels of estrogen, but there may be a lack of sensitivity to estrogen in the hypothalamus and pituitary."
What's important for women to know, said Goldsmith, is that there are "real biochemical changes occurring during menopause." Researchers are beginning to understand how those changes start to occur, which is the first step in trying to come up with more effective treatments.
SOURCES: Gerson Weiss, M.D., professor and chairman, obstetrics and gynecology and women's health; Laura Goldsmith, Ph.D., professor, obstetrics and gynecology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark; Steven Goldstein, M.D., professor , obstetrics and gynecology, and obstetrician/gynecologist, New York University School of Medicine and Medical Center, New York City; Dec. 22/29, 2004, Journal of the American Medical Association
For more information visit by clicking here
But new research challenges that assumption, and instead suggests that menopausal symptoms, at least in part, may begin in the brain.
That's because the hypothalamus and the pituitary gland stop reacting normally to estrogen in some women, suggesting they may have developed a reduced sensitivity to estrogen, researchers at the New Jersey Medical School report in the Dec. 22/29 issue of the Journal of the American Medical Association.
"This is an important new concept: Menopause doesn't just originate in the ovary, but also in the brain," said Laura Goldsmith, a professor of obstetrics and gynecology and women's health at the New Jersey Medical School of the University of Medicine and Dentistry of New Jersey.
These findings may lead the way to further research that will ultimately help doctors predict the type of menopausal transition a woman might have, and help to design non-estrogen medications that could help reduce symptoms that women experience as they enter this phase of life, said Dr. Gerson Weiss, chairman of obstetrics and gynecology and women's health at the New Jersey Medical School.
Menopause refers to the time when menstruation stops. A woman is not considered menopausal until she has not had a period for 12 consecutive months, according to the North American Menopausal Society. The time before menopause, which is often rife with symptoms due to hormonal fluctuations, is called perimenopause. During perimenopause, common symptoms include hot flashes, trouble sleeping, vaginal dryness, mood swings and irregular periods.
This study stemmed from research done for the Study of Women's Health Across the Nation (SWAN), which was funded by the National Institutes of Health, that examined women's' health as they approached menopause.
The SWAN study included more than 3,300 women between the ages of 42 and 52 at the start of the study. A subset group of 840 women provided daily urine samples, which were tested for hormone levels. The samples were collected daily for one full menstrual cycle or 50 days, whichever came first.
From that group, the researchers learned that 160 did not ovulate. After further analyzing the hormone levels from the non-ovulating women, the researchers discovered that these women fell into three distinct groups.
The first group had an increase in their levels of estrogen, and then had an appropriate surge of luteinizing hormone (LH) that should have triggered ovulation, but didn't. According to Weiss, this lack of response indicated a problem originating in the ovary.
In the second group, estrogen levels peaked, but there was no correlating surge in LH, which Weiss said should be triggered by the hypothalamus and pituitary gland responding to higher estrogen levels.
The third group had similar estrogen levels early in their cycles, but didn't have an increase in estrogen later as the first and second groups did. LH levels didn't surge, but were higher for most of the cycle than they were in the other groups.
According to Weiss, this is "clear evidence that the brain is not responding to hormones," suggesting the second and third groups showed different kinds of decreased sensitivity to estrogen in the brain.
The women in the third group were also the ones most likely to report symptoms, such as hot flashes and night sweats.
Goldsmith said the researchers hope to continue studying these women. She said they'd especially like to learn how the timing of menopause correlates with their findings. For example, the researchers would like to see if the women in the third group were, perhaps, further along in the menopausal process.
"It appears that what's going on in menopause isn't only ovarian," said Dr. Steven Goldstein, a professor of obstetrics and gynecology at New York University School of Medicine. "We thought the pituitary responded to lower levels of estrogen, but there may be a lack of sensitivity to estrogen in the hypothalamus and pituitary."
What's important for women to know, said Goldsmith, is that there are "real biochemical changes occurring during menopause." Researchers are beginning to understand how those changes start to occur, which is the first step in trying to come up with more effective treatments.
SOURCES: Gerson Weiss, M.D., professor and chairman, obstetrics and gynecology and women's health; Laura Goldsmith, Ph.D., professor, obstetrics and gynecology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark; Steven Goldstein, M.D., professor , obstetrics and gynecology, and obstetrician/gynecologist, New York University School of Medicine and Medical Center, New York City; Dec. 22/29, 2004, Journal of the American Medical Association
For more information visit by clicking here
Tuesday, June 03, 2008
Study Finds Menopause Symptoms Can Be Predicted
The number of eggs left in a woman's ovaries are like the grains of sand in an hourglass, ticking away the hours on her biological clock.
Researchers now say they may be able to predict when that clock will wind down.
And while doctors can't actually count the number of eggs in an ovary, they can measure ovarian volume. British researchers say there's a direct correlation between the two, and by measuring ovarian volume with transvaginal ultrasound, doctors should be able to predict when menopause will set in and how many fertile years a woman has left.
According to the study authors, this information will revolutionize the care of women looking for assisted reproductive technologies, including those who were treated for childhood cancers as well as women who want to put off starting a family for whatever reason.
Although information still needs to be validated in clinical studies, its benefit is most likely to start with women who are being treated for cancer and women attending fertility clinics, said Tom Kelsey, co-author of the study appearing June 17 in the journal Human Reproduction.
"If women looking for some sort of assisted conception and their physicians know that they've got a long time till menopause, then you could plan for a range of treatments," said Kelsey, who is a senior research fellow at the University of St. Andrews in Scotland. "If you knew menopause was likely in four to five years, you'd plan a different set of IVF [in vitro fertilization] treatments."
Others reiterate, however, that the findings should be treated with caution.
"Should a young woman who is 30 years old go for a test to figure out whether she's got three, five or 10 years left on her fertility? Should she make career decisions and life decisions? Are these data good enough to make those determinations?" asked Dr. Alan Copperman, director of reproductive medicine at Mount Sinai Medical Center in New York City. "The answer is obviously no to all of those questions. The predictive value of this test is not good enough to go and tell someone to change their life."
According to the article, eggs form in a female's ovary while she is still in the womb, peaking at several million about halfway through gestation and then starting a continuous decline. At birth, there are several hundred thousand and, when menstruation begins, about 300,000. At about age 37, a woman has about 25,000 eggs left, and at menopause only about 1,000.
The time at which menopause sets in is widely believed to be based on the number of eggs reaching a critically low threshold.
The authors of this study measured ovarian volume with transvaginal ultrasound, then looked at the relationship between ovarian volume -- ovaries shrink as a woman ages -- and number of eggs. They then applied mathematical and computer models to predict menopause.
The study authors are negotiating with a medical school to set up clinical trials. The idea would be to follow women to see if their predictions were indeed correct.
While these authors have come up with a tool to potentially help women plan their lives, a second study in the same issue of Human Reproduction warned that women might not want to leave it too late. Assisted reproductive technology (ART) could not be relied upon to fully compensate for lack of natural fertility after the age of 35, the article stated.
The authors used a computer simulation model to determine that the overall success rate of assisted reproductive technology would be 30 percent for those attempting to get pregnant from age 30, 24 percent for those trying from age 35, and 17 percent from age 40.
SOURCES: Tom Kelsey, Ph.D., senior research fellow, University of St. Andrews, St. Andrews, Scotland; Alan Copperman, M.D., director, reproductive medicine, Mount Sinai Medical Center, New York; June 17, 2004, Human Reproduction
For more information visit here
Researchers now say they may be able to predict when that clock will wind down.
And while doctors can't actually count the number of eggs in an ovary, they can measure ovarian volume. British researchers say there's a direct correlation between the two, and by measuring ovarian volume with transvaginal ultrasound, doctors should be able to predict when menopause will set in and how many fertile years a woman has left.
According to the study authors, this information will revolutionize the care of women looking for assisted reproductive technologies, including those who were treated for childhood cancers as well as women who want to put off starting a family for whatever reason.
Although information still needs to be validated in clinical studies, its benefit is most likely to start with women who are being treated for cancer and women attending fertility clinics, said Tom Kelsey, co-author of the study appearing June 17 in the journal Human Reproduction.
"If women looking for some sort of assisted conception and their physicians know that they've got a long time till menopause, then you could plan for a range of treatments," said Kelsey, who is a senior research fellow at the University of St. Andrews in Scotland. "If you knew menopause was likely in four to five years, you'd plan a different set of IVF [in vitro fertilization] treatments."
Others reiterate, however, that the findings should be treated with caution.
"Should a young woman who is 30 years old go for a test to figure out whether she's got three, five or 10 years left on her fertility? Should she make career decisions and life decisions? Are these data good enough to make those determinations?" asked Dr. Alan Copperman, director of reproductive medicine at Mount Sinai Medical Center in New York City. "The answer is obviously no to all of those questions. The predictive value of this test is not good enough to go and tell someone to change their life."
According to the article, eggs form in a female's ovary while she is still in the womb, peaking at several million about halfway through gestation and then starting a continuous decline. At birth, there are several hundred thousand and, when menstruation begins, about 300,000. At about age 37, a woman has about 25,000 eggs left, and at menopause only about 1,000.
The time at which menopause sets in is widely believed to be based on the number of eggs reaching a critically low threshold.
The authors of this study measured ovarian volume with transvaginal ultrasound, then looked at the relationship between ovarian volume -- ovaries shrink as a woman ages -- and number of eggs. They then applied mathematical and computer models to predict menopause.
The study authors are negotiating with a medical school to set up clinical trials. The idea would be to follow women to see if their predictions were indeed correct.
While these authors have come up with a tool to potentially help women plan their lives, a second study in the same issue of Human Reproduction warned that women might not want to leave it too late. Assisted reproductive technology (ART) could not be relied upon to fully compensate for lack of natural fertility after the age of 35, the article stated.
The authors used a computer simulation model to determine that the overall success rate of assisted reproductive technology would be 30 percent for those attempting to get pregnant from age 30, 24 percent for those trying from age 35, and 17 percent from age 40.
SOURCES: Tom Kelsey, Ph.D., senior research fellow, University of St. Andrews, St. Andrews, Scotland; Alan Copperman, M.D., director, reproductive medicine, Mount Sinai Medical Center, New York; June 17, 2004, Human Reproduction
For more information visit here
Subscribe to:
Posts (Atom)
